Physician profile
Sanjay K Sikka
NPI 1528295698
$30,824.76
in general payments reported to CMS, 2019-2025
19 companies · $1,996 in 2025
The $1,996 reported for 2025 was more than what 79% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $1,221 · 2021: $2,008 · 2022: $20K · 2023: $3,632 · 2024: $190 · 2025: $1,996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,911 · Food and Beverage: $2,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,911.19 |
| Food and Beverage | $2,906.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,276.03 | 2019-2025 | Orise, Exalt Model D, Acquire |
| Olympus Corporation of The Americas | $5,254.85 | 2020-2023 | Disposable Distal Attachment, Olympus |
| Cook Medical LLC | $1,214.50 | 2021-2025 | Echotip Insight, Echotip, Fusion |
| Olympus America INC. | $675.99 | 2019-2022 | |
| Abbvie INC. | $351.09 | 2019-2024 | |
| Lumendi LLC | $223.39 | 2022 | |
| Ambu INC. | $158.93 | 2020 | |
| Vifor Pharma, INC. | $119.69 | 2019 | |
| Steris Corporation | $107.04 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $101.46 | 2021 | |
| Intercept Pharmaceuticals, INC. | $97.70 | 2022 | |
| Janssen Biotech, INC. | $60.75 | 2022 | |
| Celgene Corporation | $56.65 | 2022-2023 | Zeposia |
| Braintree Laboratories, INC. | $53.32 | 2020 | |
| Genzyme Corporation | $17.83 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.36 | 2021 | |
| Coloplast Corp | $15.36 | 2023 | Titan |
| Covidien LP | $14.34 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $10.48 | 2024 | Lockado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Sikka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.